Anti-Saccharomyces cerevisiae antibody and 5-aminosalicylic acid treatment.
Oshitani
Nobuhide
N
D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis / Q000276:immunology*; D000908:Antibodies, Fungal / Q000032:analysis / Q000276:immunology*; D015415:Biomarkers / Q000032:analysis; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D012441:Saccharomyces cerevisiae / Q000276:immunology*; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D000636:Aminosalicylic Acids; D000888:Antibodies, Anti-Idiotypic; D000908:Antibodies, Fungal; D015415:Biomarkers